Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
On Thursday, Centene Corporation (NYSE:CNC) outlined its 2025 financial guidance.
週四，康西哥公司（紐交所：CNC）概述了其2025年的財務指導。
For fiscal year 2025, the health insurance plan provider expects total revenues of $166.5 billion to $169.5 billion, compared to a consensus of $166.58 billion.
對於2025財年，該健康保險計劃提供商預計總收入在1665億到1695億之間，而市場共識爲1665.8億。
The guidance includes premium and service revenues of $154.0 billion to $156.0 billion. The company expects GAAP EPS of greater than $6.19, with adjusted EPS of greater than $7.25 compared to the consensus of $6.97.
該指導包括1540億到1560億的保費和服務收入。公司預計GAAP每股收益大於6.19美元，調整後的攤薄後每股收益大於7.25美元，而市場共識爲6.97美元。
Also Read: Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
相關閱讀：特朗普的第二個任期可能重塑美國醫療保健體系，對可負擔醫療法案和醫療保險造成重大影響。
The company expects a Health benefits ratio (HBR) of 88.4% to 89.0%.
公司預計健康福利比率（HBR）在88.4%到89.0%之間。
The insurer forecasts a 2025 selling, general, and administrative (SG&A) expense ratio of 8.1% to 8.7%, with an adjusted SG&A expense ratio of 8.1% to 8.7%.
該保險公司預計2025年的銷售、一般和管理（SG&A）開支比率爲8.1%到8.7%，調整後的SG&A開支比率爲8.1%到8.7%。
The company reaffirms its 2024 premium and service revenues guidance if $143.5 billion to $144.5 billion, HBR guidance if 88.3% to 88.5%, and adjusted diluted EPS guidance of greater than $6.80.
公司重申2024年保費和服務收入指導爲1435億到1445億，HBR指導爲88.3%到88.5%，以及調整後的攤薄後每股收益指導大於6.80美元。
"Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customers and providers, all while delivering on our financial commitments," said Chief Executive Officer of Centene, Sarah London.
「康西哥是一家以使命爲導向的組織，致力於爲2800萬多名成員提供高質量的成果，其中許多人屬於全國最複雜的醫療和歷史上服務不足的人群。在過去三年中，我們改善了核心業務，並投資於客戶和供應商的體驗，同時履行我們的財務承諾，」康西哥首席執行官莎拉·倫敦（Sarah London）說。
Full-year 2024 earnings will be reported on February 4, 2025.
2024年全年收益將於2025年2月4日公佈。
Price Action: CNC stock is up 1.92% at $57.99 at the last check on Thursday.
價格走勢：CNC股票在週四最後檢查時上漲1.92%，報57.99美元。
- Keros Therapeutics Loses 75% Value In A Single Session – Here's Why
- Keros Therapeutics在單個交易日內損失75%的價值——這就是原因。
譯文內容由第三人軟體翻譯。
